Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
news
This is the Cardiovascular Diabetology news archive.

Old news items may link to websites that are no longer available.
Cardiovascular Diabetology News for the last 365 days

The ACCORD study group: The combination of fenofibrate and simvastatin did not reduce the rate of fatal cardiovascular events, nonfatal myocardial infarction, or nonfatal stroke, as compared with simvastatin alone. N Engl J Med, March 2010
(Date posted: 19 March 2010)

Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort. Metabolism, February 2010
(Date posted: 2 March 2010)

Statin therapy is associated with a slightly increased risk of development of diabetes, but the risk is low both in absolute terms and when compared with the reduction in coronary events. The Lancet, February 2010
(Date posted: 22 February 2010)

Effects of diabetes family history and exercise training on the expression of adiponectin and leptin and their receptors. Metabolism, February 2010
(Date posted: 17 February 2010)

In obesity, waist-to-hip ratio (WHR) was the only significant predictor of incident CVD, and the relationship between WHR and risk of CVD was mediated by well-known risk factors of CVD. Eur J Cardiovasc Prev Rehabil, February 2010
(Date posted: 6 February 2010)

Low and high mean HbA(1c) values were associated with increased all-cause mortality and cardiac events. Diabetes guidelines might need revision to include a minimum HbA(1c) value. The Lancet, January 2010
(Date posted: 2 February 2010)

Barriers to insulin initiation: The Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Care, January 2010
(Date posted: 21 January 2010)

List of Referees, 2009. The Editors of Cardiovascular Diabetology feel privileged for the contribution of reviewers and members of our Editorial Board, and wish to pay tribute for their crucial service in moving ahead the scientific level of the Journal.
(Date posted: 18 January 2010)

An algorithm able to stratify which diabetic patients present with a low, intermediate or high risk of myocardial ischaemia based on myocardial perfusion scintigraphy. Diabetologia, January 2010
(Date posted: 18 January 2010)

Heart rate-corrected QT interval in resting ECG predicts the risk for development of type-2 diabetes mellitus. European Journal of Epidemiology, January 2010
(Date posted: 14 January 2010)

The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia, January 2010
(Date posted: 9 January 2010)

Middle-aged men with metabolic syndrome had increased risk for cardiovascular events and total death regardless of BMI status during more than 30 years of follow-up. Circulation, December 2009
(Date posted: 31 December 2009)

Midregional pro-A-type natriuretic peptide has a comparable accuracy to BNP for the evaluation of exercise intolerance. International Journal of Cardiology, December 2009
(Date posted: 27 December 2009)

Statin therapy is associated with decreased myocardial function as evaluated with strain imaging (SI). Clinical Cardiology, December 2009
(Date posted: 23 December 2009)

Androgen deprivation therapy with GnRH agonists for prostate cancer is associated with an increased risk of diabetes and cardiovascular disease. Journal of the National Cancer Institute, December 2009
(Date posted: 11 December 2009)

Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: Findings from the Heart and Soul Study. Psychiatry Research, December 2009
(Date posted: 10 December 2009)

Increased adiposity enhances production of thrombin in adipose tissue by stimulating factor VII suggesting that this fact plays an important role in development of insulin resistance in an experimental model. Endocrinology, December 2009
(Date posted: 9 December 2009)

Effect of statins on HDL: a complex process unrelated to changes in LDL: Analysis of the VOYAGER Database. Journal of Lipid Research, December 2009
(Date posted: 8 December 2009)

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ, December 2009
(Date posted: 7 December 2009)

The metabolic syndrome predicts incident congestive heart failure: A 20-year follow-up study of elderly finns. Atherosclerosis, November 2009
(Date posted: 1 December 2009)

NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia, November 2009
(Date posted: 29 November 2009)

Selective peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) modulation as a strategy for safer therapeutic PPAR{gamma} activation. American Journal of Clinical Nutrition, November 2009
(Date posted: 16 November 2009)

The 5th Congress of Nephrology in Internet, CIN2009, will take place on November 15-30. The Scientific Program is already available.
(Date posted: 18 October 2009)

In apparently healthy men, circulating total adiponectin, adipsin, resistin, leptin and PAI-1 were not independent predictors of future CHD event. International Journal of Obesity (London), October 2009
(Date posted: 14 October 2009)

Carperitide infusion increases the plasma adiponectin level, especially in acute decompensated heart failure patients with diabetes mellitus. Circulation Journal, October 2009
(Date posted: 6 October 2009)

Superoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetes. Metabolism, September 2009
(Date posted: 26 September 2009)

Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetologia, September 2009
(Date posted: 16 September 2009)

Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine, September 2009
(Date posted: 1 September 2009)

Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy. The Journal of Physiology, August 2009
(Date posted: 15 August 2009)

APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Archives of Internal Medicine, August 2009
(Date posted: 12 August 2009)

Plasticity of heart rate signalling and complexity with exercise training in obese individuals with and without type 2 diabetes. International Journal of Obesity (London), August 2009
(Date posted: 6 August 2009)

Suppressor of cytokine signalling-3 inhibits tumor necrosis factor-alpha induced apoptosis and signalling in beta cells. Molecular and Cellular Endocrinology, July 2009
(Date posted: 2 August 2009)

Diabetic condition impairs the elastic properties of arteries, independent of other known atherosclerotic risk factors or excessive intimal disease. Atherosclerosis, July 2009
(Date posted: 29 July 2009)

Advanced glycation end products strongly activate platelets. European Journal of Nutrition, August 2009
(Date posted: 28 July 2009)

Increased insulin resistance does not predict incident cerebrovascular events amongst patients with pre-existing atherothrombotic disease. European Journal of Neurology, July 2009
(Date posted: 19 July 2009)

Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. Lancet, July 2009
(Date posted: 15 July 2009)

Combination of cardiorespiratory reflex parameters and heart rate variability power spectrum analysis for early diagnosis of diabetic cardiac autonomic neuropathy. Diabetes and Metabolism, June 2009
(Date posted: 3 July 2009)

Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury. Journal of Cellular Biochemistry, June 2009
(Date posted: 25 June 2009)

Modest reductions in prevalence of major cardiovascular risk factors account for more than twice as many life-years gained as do treatments. These gains are partially offset by increases in obesity and diabetes. American Journal of Epidemiology, June 2009
(Date posted: 23 June 2009)

Myeloid-Related Protein 14 (Mrp-14) is strongly associated with the histologic features and the inflammatory status of rupture-prone lesions, identifying Mrp-14 as local marker for these plaques. Arteriosclerosis, Thrombosis & Vascular Biology, June 2009
(Date posted: 15 June 2009)

Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus. Journal of Cardiology, June 2009
(Date posted: 2 June 2009)

The prevalence of asymptomatic LV dysfunction in subjects at risk for HF is 5.1%. Because of its excellent NPV, NT-proBNP can be used to rule out it in hypertensive or diabetic patients. Journal of Cardiac Failure, June 2009
(Date posted: 1 June 2009)

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood, May 2009
(Date posted: 16 May 2009)

Relationship between coronary atherosclerotic plaques and traditional risk factors in people with no history of cardiovascular disease undergoing multi-detector computed coronary angiography. Heart, April 2009
(Date posted: 3 May 2009)

Glycated hemoglobin level and subsequent mortality among adults in the U.S. Diabetes Care, April 2009
(Date posted: 1 May 2009)

Reconstitued HDL reduces plasma glucose in patients with type 2 diabetes mellitus by increasing plasma insulin and activating AMP-activated protein kinase in skeletal muscle. Circulation, April 2009
(Date posted: 14 April 2009)

Increased morbidity in diabetic cardiac transplant recipients. Canadian Journal of Cardiology, April 2009
(Date posted: 5 April 2009)

The challenges associated with current clinical trials for diastolic heart failure. Current Opinion in Cardiology, March 2009
(Date posted: 28 March 2009)


register
Cardiovascular Diabetology
BioMed Central
Current Controlled
Trials
PubMed
PubMed Central


Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.